Alkermes (ALKS) Change in Receivables (2010 - 2026)
Alkermes (ALKS) reported Change in Receivables of $23.2 million for Q1 2026, up 135.27% year-over-year from $9.9 million in Q1 2025, and up 213.98% quarter-over-quarter from -$20.4 million in Q4 2025.
Alkermes (ALKS) Change in Receivables (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has 17 years of Change in Receivables data on file, last reported at $23.2 million in Q1 2026.
- Change in Receivables for Q1 2026 came in at $23.2 million, up 135.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $38.5 million (up 1249.84% YoY), and the FY2025 annual result was -$50.5 million, down 197.02% from the prior year.
- Change in Receivables grew to $23.2 million in Q1 2026 per ALKS's latest filing, from -$20.4 million in the prior quarter.
- Over five years, Change in Receivables peaked at $65.3 million in Q2 2023 and troughed at -$65.8 million in Q1 2025.
- A 5-year average of $2.6 million and a median of $795000.0 in 2024 frame the typical range for Change in Receivables.
- The sharpest annual moves came in 2023 and 2025: Change in Receivables jumped 1695.8% in 2023, then tumbled 295.87% in 2025.
- A 5-year view of Change in Receivables shows it stood at $30.8 million in 2022, then slumped by 116.95% to -$5.2 million in 2023, then jumped by 431.76% to $17.3 million in 2024, then plunged by 217.62% to -$20.4 million in 2025, then jumped by 213.98% to $23.2 million in 2026.
- Business Quant data shows ALKS's Change in Receivables at $23.2 million in Q1 2026, -$20.4 million in Q4 2025, and -$512000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -78.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 106.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -38.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 81.40 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 23.22 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 2.23 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 116.25 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 20.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.22 Mn |
| Mar 31, 2026 | 23.22 Mn |
| Dec 31, 2025 | -20.37 Mn |
| Dec 31, 2025 | -20.37 Mn |
| Sep 30, 2025 | -512,000.00 |
| Sep 30, 2025 | -512,000.00 |
| Jun 30, 2025 | 36.20 Mn |
| Jun 30, 2025 | 36.20 Mn |
| Mar 31, 2025 | -65.83 Mn |
| Mar 31, 2025 | -65.83 Mn |
| Dec 31, 2024 | 17.32 Mn |
| Dec 31, 2024 | 17.32 Mn |
| Sep 30, 2024 | 795,000.00 |
| Sep 30, 2024 | 795,000.00 |
| Jun 30, 2024 | 50.57 Mn |
| Jun 30, 2024 | 50.57 Mn |
| Mar 31, 2024 | -16.63 Mn |
| Mar 31, 2024 | -16.63 Mn |
| Dec 31, 2023 | -5.22 Mn |
| Dec 31, 2023 | -5.22 Mn |